Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Gamechanger
View:
Post by SleepyHoward on Mar 05, 2024 11:18am

Gamechanger

Zero Volume.
Great job Mr verrico
Comment by tylerreddick on Mar 05, 2024 1:39pm
Well, at least no one is selling into the stinky 8-cent bid. Yeah, I know, that is a small comfort after all of the glowing promises Howie has made over the years, promises that turned into bull excrement.
Comment by MirrorWorldMan on Mar 05, 2024 5:46pm
Zero volume at historically low share prices, makes shares and warrants  pretty much worthless, and is almost the worst case scenario.  Remember Howies declared dedication to increase shareholder value? No results, no numbers, no launch dates. But lots of talk about internal strategic direction initiatives, that end up nowhere.  All he has to do is release the detail of the skim ...more  
Comment by Pareto8020 on Mar 06, 2024 10:12am
This goes way back so probably only the oldtimers will remember but when SBM did the deal with Obagi that got stretched out to the point where they developed addtional lightening compounds that were even better then the one licensed to Obagi.  Then when it finally came time for Obagi to work on formulating the compound into their products it was determined it was too costly of a process and ...more  
Comment by biorun on Mar 06, 2024 10:57am
Well said and very true. As I have mentioned before, the better quality the partner, the higher likelihood of success for us shareholders. AbbVie/Allergan seem to be the highest rated organization from both size/magnitude and market presence point of view to date out of all those you listed.  While I remain hopeful they announce a launch sooner than later, I reiterate the most logical time ...more  
Comment by biorun on Mar 06, 2024 11:02am
Sorry, to finish my thought, if that scenario plays out between now and next fall, we should see some fireworks that will hopefully restore a little faith in the institution that has the privilege of bringing to light the amazing science.
Comment by lscfa on Mar 06, 2024 12:41pm
R+F launched a product 18 months after deal with Sirona. What the hell is taking Abbvie so long?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities